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RNA has emerged as the prime target for diagnostics, therapeutics and the
development of personalized medicine. In particular, the non-coding RNAs (ncRNAs)
that do not encode proteins, display remarkable biochemical versatility. They can fold
into complex structures and interact with proteins, DNA and other RNAs, modulating
the activity, DNA targets or partners of multiprotein complexes. Thus, ncRNAs confer
regulatory plasticity and represent a new layer of epigenetic control that is dysregulated
in disease. Intriguingly, for long non-coding RNAs (lncRNAs, >200 nucleotides length)
structural conservation rather than nucleotide sequence conservation seems to be
crucial for maintaining their function. LncRNAs tend to acquire complex secondary and
tertiary structures and their functions only impose very subtle sequence constraints.
In the present review we will discuss the biochemical assays that can be employed
to determine the lncRNA structural configurations. The implications and challenges of
linking function and lncRNA structure to design novel RNA therapeutic approaches will
also be analyzed.
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INTRODUCTION
The HUMAN GENOME project has transformed our understanding of the basic unit of genetic
information with RNA emerging as a versatile regulator of central cellular processes (Thum and
Condorelli, 2015). The non-coding RNAs (ncRNAs), transcripts that do not encode proteins
comprise the biggest class and are arbitrarily divided into small (<200 nucleotides) and long
non-coding RNAs (lncRNA (>200 nucleotides). MicroRNAs (miRNAs) are the best studied
small ncRNAs, representing an additional layer of posttranscriptional regulators that absorb
perturbations and ensure the robustness of biological systems (Liu and Olson, 2010; Ebert and
Sharp, 2012; Rotllan et al., 2016).
Substantial effort has now been directed toward dissecting the function of lncRNAs. In the
cardiovascular system, lncRNAs were reported to play key roles in physiology and disease and
targeting lncRNAs for novel therapeutic interventions has been explored (Uchida and Dimmeler,
2015; Boon et al., 2016; Buhrke et al., 2018). Here we will discuss the experimental tools to
determine the RNA structure that can offer unique insights into the lncRNA function in the
cardiovascular system.
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CHALLENGES IN ASSESSING lncRNA
FUNCTIONALITY
The unique features of lncRNA have been extensive investigated
(Guttman and Rinn, 2012; Ulitsky and Bartel, 2013; Bar et al.,
2016; Ulitsky, 2016). Several characteristics of lncRNAs make
functional evaluation challenging. Typically, lncRNAs display
poor conservation across species showing only “patches” of
conserved bases surrounded by large seemingly unconstrained
sequences (Ponjavic et al., 2007; Guttman et al., 2009; Necsulea
et al., 2014; Washietl et al., 2014). Additionally, lncRNAs
exhibit low abundance that restricts their mode and sites of
action (Mercer et al., 2008; Cabili et al., 2011, 2015; Washietl
et al., 2014; Ulitsky, 2016; Wilk et al., 2016; Jandura and
Krause, 2017). In terms of the modes of function, both cis-
and trans-regulatory activity have been described (Mercer and
Mattick, 2013). As cis-regulators, lncRNAs exert their function
on neighboring genes on the same allele from which they are
transcribed, displaying expression correlation and perturbation
in an allele-specific manner. CARMEN, an enhancer associated
lncRNA and a crucial regulator of cardiac specification in human
cardiac progenitor cells was shown to act in cis to control
the expression of miR-143/145 (Ounzain et al., 2015). On the
other hand, acting in trans-lncRNAs can control gene expression
at a distance from their transcription site, by altering the
chromatin state, influencing the nuclear structure or regulating
protein function (Vance and Ponting, 2014; Kopp and Mendell,
2018).
Intriguingly, for some low abundance lncRNAs the act of
transcription seems to be more important than the transcript
itself. In a seminal study, Engreitz et al. (2016) genetically
manipulated 12 genomic loci that produce lncRNAs to find that
5 loci influenced the expression of a neighboring gene in cis.
The expression of the lncRNAs transcripts themselves was not
required but instead processes associated with their transcription
were critical (Engreitz et al., 2016).
THE RNA INTERACTOME
The above functional versatilities of lncRNAs stem from
their ability to conform to different structures and molecular
interactions with proteins, RNA and DNA (Guttman and
Rinn, 2012; Marchese et al., 2017). In ribonucleoprotein
complexes (RNPs), lncRNAs may act as scaffolds to stabilize
the complexes, directing them to specific subcellular loci or the
DNA. In endothelial cells, interaction of the lncRNA MANTIS
with the ATPase catalytic subunits confers specificity to the
switch/sucrose non-ferentable (SWI/SNF) chromatin remodeling
complex directing it to a subset of angiogenic genes and
facilitating nucleosome remodeling and transcription initiation
(Leisegang et al., 2017; Zampetaki and Mayr, 2017). In fact
binding of lncRNA to specific ATPase subunits of the SWI/SNF
complex is a common regulatory mechanism (Cajigas et al., 2015;
Zhu et al., 2016).
Interaction of lncRNAs with chromatin complexes is
particularly important as these lncRNA-RNPs can trigger
chromatin modifications through interference with the
chromatin-modifying machinery (Tsai et al., 2010; Brockdorff,
2013; Simon et al., 2013). In the heart, Chaer a cardiac enriched
lncRNA acts as an epigenetic switch by interfering with
the polycomb repressive complex 2 (PRC2) and inhibiting
H3K27m3 at genes involved in cardiac hypertrophy (Wang
et al., 2016), while mesoderm faith determining lncRNA
Fendrr can bind to both PRC2 and Trithorax group/MLL
(TrxG/MLL) complexes acting as a fine tuner (Grote et al.,
2013).
Apart from proteins, interaction of lncRNAs with DNA
has also been described. This can lead to the formation of
RNA-DNA triplex, a structure that is widespread in vivo and
facilitates target gene recognition by lncRNAs (Mondal et al.,
2015). This interaction was elegantly demonstrated in MEG3,
a cardiac fibroblast enriched lncRNA that promotes fibrosis
(Piccoli et al., 2017). MEG3 interacts with the PRC2 complex and
forms RNA-DNA triplex structures through GA-rich sequence
binding sites. Chromatin RNA immunoprecipitation revealed
that MEG3 modulates the activity of TGF-b pathway genes and
target recognition occurs via the triplex structures (Mondal et al.,
2015).
Long non-coding RNA regulatory functions also rely on
RNA–RNA interactions. Crosstalk with miRNAs creates an
intricate network that exerts post-transcriptional regulation of
gene expression. LncRNAs can harbor miRNA binding sites
and act as molecular decoys or sponges that sequester miRNAs
away from other transcripts. Noteworthy, competition between
lncRNAs and miRNAs for binding to target mRNAs has been
reported and leads to de-repression of gene expression (Yoon
et al., 2014; Ballantyne et al., 2016). Finally, lncRNAs may contain
embedded miRNA sequences and serve as a source of miRNAs
(Piccoli et al., 2017).
LINKING RNA STRUCTURE TO
FUNCTION
RNA molecules adopt higher order tertiary interactions (Staple
and Butcher, 2005; Wan et al., 2011). Although links between
structure and function are emerging, the structural domains
that dominate the RNA interactome are still not well defined.
The functional implications of transcript structure are better
understood in the processing the primary miRNAs (primiRNAs)
to mature miRNAs. Using multiple mutagenesis assays, the
secondary structures such as stem length, hairpin pairing, bulge
size and position, and apical loop size that contribute to effective
miRNA biogenesis were defined (Auyeung et al., 2013; Fang
and Bartel, 2015; Nguyen et al., 2015; Roden et al., 2017).
In clustered miRNAs that consist of multiple miRNA genes,
the tertiary structure was also proposed to contribute to the
processing to individual mature miRNAs. An autoregulatory role
for the tertiary structure of miR-17∼92 cluster in its maturation
and binding of auxiliary factors to conserved terminal loops
was shown (Chakraborty et al., 2012). Recently, in the miR-
497∼195 cluster, mutations in miR-195a hairpin were reported
to affect the processing of miR-497a that resides in the same
Frontiers in Physiology | www.frontiersin.org 2 August 2018 | Volume 9 | Article 1201
fphys-09-01201 August 23, 2018 Time: 9:4 # 3
Zampetaki et al. Linking Structure to lncRNA Function
cluster. Computational analysis highlighted differences in the
tertiary structure of the primiRNA in mutants that may affect the
maturation process (Lataniotis et al., 2017). On a different note, in
primiR-30c-1 the tertiary structure promotes the interaction with
SRSF3, an SR protein family member that facilitates primiRNA
recognition and processing. A single G/A sequence variation
leads to a structural rearrangement of the apical region of the
primiRNA affecting the conserved residues placed at the basal
part of the stem and mature miRNA generation (Fernandez et al.,
2017).
In lncRNAs, selection acting on structure rather than primary
sequence may explain the rapid rate of evolution, that led to
the “RNA modular code” hypothesis based on the view that
selection acts on structural domains (Wutz et al., 2002; Tsai
et al., 2010; Guttman and Rinn, 2012). Some experimental
evidence supports this concept. TheMEG3 lncRNA gene contains
three distinct structure modules M1, M2, and M3. Deletion
analysis showed that motifs M2 and M3 are important for p53
activation. Intriguingly, a hybrid MEG3 transcript in which half
of the primary sequence in the M2 motif was replaced by an
entirely unrelated artificial sequence that displayed a similar
secondary structure was fully functional in stimulating p53-
mediated transcription (Zhang et al., 2010).
RNA STRUCTURE DETERMINATION
METHODS
Chemical and enzymatic probing methods can provide an
understanding of the secondary structure of RNA (Ehresmann
et al., 1987). Enzymatic probing relies on nucleases that bind
to paired and unpaired RNA and digest it to generate RNA
fragments that can be analyzed. On the other hand, in chemical
probing small size chemicals that react and covalently modify
solvent accessible nucleotides are used. Following modification or
cleavage, positions are typically mapped by reverse transcription,
which either stops or introduces a mutation into the cDNA
(Wilkinson et al., 2006). An analysis of the resulting cDNA is
then used to determine the nucleotide position and modification
frequency. Next generation sequencing (NGS) can be applied
to directly sequence the cDNA products. This allows RNA
structural characterization at a transcriptome-wide level in a
single experiment (Lucks et al., 2011; Incarnato et al., 2014;
Loughrey et al., 2014; Rouskin et al., 2014). Although initially the
technologies were established to analyse RNA structure in vitro,
structural characterization in vivo mainly through the use of
probes that can diffuse quickly across membranes has also been
reported (Spitale et al., 2013; Ding et al., 2014; Spitale et al., 2015;
Flynn et al., 2016).
ENZYMATIC PROBING
PARS
PARS (parallel analysis of RNA structure) is a high-throughput
enzymatic probing method that measures the structural
properties of isolated polyadenylated transcript pools that are
renatured in vitro and treated with RNase V1 or S1. RNase V1 and
RNase S1 cleave the 3′ phosphodiester bonds of double-stranded
and single-stranded RNA, respectively, allowing evaluation of the
double- or single-stranded conformation (Kertesz et al., 2010).
Frag-Seq
Frag-Seq (fragmentation sequencing) is an enzymatic method
that uses a nuclease P1 to specifically cleave single-stranded
RNA. High-throughput sequencing then analyses the fragments
generated. This workflow provides an “RNA accessibility
profile” that is likened to the DNase hypersensitivity assays
on chromatin (Underwood et al., 2010). Noteworthy, Frag-
seq isolates fragments <200 bases after RNase P1 cleavage,
hence large RNAs maybe underrepresented. As Frag-seq and
PARS can provide complementary data a combined approach
could improve the accuracy of genome-wide RNA structure
measurements (Wan et al., 2011).
CHEMICAL PROBING
DMS Probing
The dimethyl sulfate (DMS) is a base specific reagent that can
bind and alter the methylation state of unpaired adenosine and
cytosine nucleotides (Tijerina et al., 2007; Rouskin et al., 2014).
DMS footprinting is optimized for structural analysis of RNA.
Protein binding to RNA generates a “footprint” that can be traced
due to alterations in the RNA structure. The transcript size that
can be evaluated is rather small (<500 nt) but this method can be
performed both in vitro and in vivo as DMS can easily penetrate
the cell membrane. DMS-seq that combines DMS methylation
with NGS was recently performed in vivo (Ding et al., 2014;
Rouskin et al., 2014).
Targeted Structure-Seq
Targeted Structure-Seq relies on RNA methylation by DMS being
performed in vivo. Subsequently, RNA is isolated from cells and
the methylation sites are determined by employing gene specific
primers for the reverse transcription reaction. Sequencing of
the DMS derived fragments can be used to assess the cellular
conformation of the RNA. Based on this method, structural
models of elements within Xist were developed (Fang et al., 2015).
Although initially reported using DMS this workflow can be
adapted for other probing reagents.
SHAPE
SHAPE (selective 2′-hydroxyl acylation by primer extension) can
interrogate the RNA structure both in vitro and in vivo using
the chemical NMIA and its derivatives to detect flexible regions
in RNA secondary structure (Wilkinson et al., 2006; Weeks and
Mauger, 2011). Several SHAPE reagents have been tested in order
to improve the signal to background ratio (Lee et al., 2017).
In SHAPE, the 2′-hydroxyl groups of all four nucleotides are
selectively acylated when flexible and unpaired. This results in
the formation of covalent SHAPE adducts that block the reverse
transcription leading to truncated cDNA fragments. SHAPE
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reactivities can then be used to model secondary structures and
quantify any process that modulates RNA dynamics.
SHAPE-MaP
SHAPE-MaP (SHAPE and mutational profiling) was the first to
combine the SHAPE protocol with NGS. Initially performed and
reported to define the HIV-1 RNA genome, SHAPE-MaP is a
highly sensitive technique that allowed rapid, de novo discovery
and direct validation of new functional motifs (Siegfried et al.,
2014; Mustoe et al., 2018).
In-cell SHAPE-Seq
In-cell SHAPE-Seq is a modification of the SHAPE-Seq
technique that combines the SHAPE-seq with gene expression
measurements to elucidate the association of RNA structure and
function in vivo. It revealed translational regulatory mechanisms
in E. coli in vivo (Watters et al., 2016).
icSHAPE-seq
icSHAPE-seq (in vivo click SHAPE sequencing) uses the
in-cell SHAPE chemical NAI-N3 followed by selective chemical
enrichment of NAI-N3-modified RNA that provides an improved
signal-to-noise ratio (Flynn et al., 2016). Follow-up NGS allows
accurate identification at single-nucleotide resolution. In mouse
embryonic stem cells it was shown that in vitro RNA folding
is programmed entirely by the sequence, whereas in vivo,
the RNA structure depends on the context of intracellular
environment and interaction with RNA binding proteins that
may lead to focal structural rearrangements (Spitale et al.,
2015). Hence, this assay offers the exciting possibility of viewing
the RNA structurome in vivo in the presence or absence of
stimulation.
RNA STRUCTUROME AND
INTERACTOME DETERMINATION
PARIS
PARIS (psoralen analysis of RNA interactions and structures)
was recently developed to determine both RNA structure
and interactions in vivo. It uses the highly specific and
reversible nucleic acid crosslinker psoralen-derivative 4′-
aminomethyltrioxsalen to fix base pairs in living cells.
Subsequently, partial RNase and complete proteinase digestion
lead to purification of a set of small crosslinked and directly
base-paired RNA fragments. Purification of the crosslinked
fragments using 2D electrophoresis, followed by proximity
ligation of duplex RNA fragments, reversal of crosslinks, and
high throughput sequencing reveals the direct base pairing
between fragments. Based on these reads, models of RNA
structures and interactions can be generated with high specificity
and sensitivity (Lu et al., 2016). Using this approach a model
for the higher order structure of Xist was interrogated (Lu et al.,
2016). Encouragingly, these findings are in agreement with
crystallographic studies of the defined domains in vitro (Arieti
et al., 2014).
lncRNA STRUCTURE DETERMINATION
Structure determination of lncRNA in vivo is extremely
challenging as they are highly heterogenic with regions with well-
defined base-pairing, others without base-pairing and regions
with multiple structures. Additionally, lncRNAs may stretch
across thousands of nucleotides, they are expressed in low
abundance and tend to be part of multicomponent complexes
(Busan and Weeks, 2017). Nevertheless, the structure of several
lncRNAs has been experimentally determined (Table 1).
Xist
This is a very long lncRNA (17,000 nucleotides) controlling
X chromosome inactivation. It spreads across the entire
chromosome while triggering stable epigenetic modifications
through recruitment of the PRC2 complex and enrichment for
the H3K27me3 repressive chromatin modification (Simon et al.,
2013; Fang et al., 2015; Smola et al., 2016). In vivo SHAPE data
identified 33 regions in Xist that form well-defined secondary
structures linked by structurally variable and dynamic regions.
RepA
This is a 1,600 nucleotides mouse lncRNA encoded by an internal
promoter on the Xist-gene sense strand. Applying SHAPE
and DMS chemical probing in vitro, an intricate structure of
three independently folding modules was revealed. Phylogenetic
analysis and computational 3D modeling demonstrated a defined
tertiary architecture that can form autonomously in the absence
of protein partners (Liu et al., 2017a).
Rox1/Rox2
In Drosophila dosage compensation is achieved using two
lncRNAs that are transcribed from the X chromosome. RNA on
the X 1 and 2 (roX1 and roX2) are 3,700 and 1,200 nucleotides in
length, respectively. In vitro SHAPE probing and PARS analysis
revealed common, conserved and distinct structural motifs that
may function as targeting sites and assembly platforms for the
male specific lethal complex (Ilik et al., 2013).
SRA
The human steroid receptor RNA activator (SRA) is an 870
nucleotide lncRNA that is derived from a gene encoding both
lncRNA and protein coding transcripts. The structure of SRA was
experimentally interrogated using SHAPE and DMS chemical
probing in vitro. In parallel, RNase V1 enzymatic probing was
performed. It was shown that SRA consists of four distinct
domains with a variety of secondary structures (Novikova
et al., 2012). More importantly, comparative structural analysis
between mouse and human strongly suggested that a large
number of evolutionary changes had minimal mutational effect
on the protein derived from the locus while stabilizing the RNA
structural core (Novikova et al., 2012).
HOTAIR
Associated with Sporadic Thoracic Aortic Aneurysm through
regulation of extracellular matrix deposition and human
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TABLE 1 | Structural Determination of lncRNAs.
lncRNA (size) Mode of
action
Function Structure Probing techniques Reference
Xist (17,000
nucleotides)
cis X-chromosome inactivation. Regions A-F with distinct
repeat sequences.
In vivo and in vitro
SHAPE-MaP. Targeted
structure Seq.PARIS
Underwood et al., 2010;
Weeks and Mauger, 2011;
Incarnato et al., 2014;
Engreitz et al., 2016
RepA (1,600
nucleotides)
cis Encoded by an internal
promoter on the Xist gene
sense strand.
Three folding modules. In vitro using chemical
probing with SHAPE and
DMS reagents.
Lee et al., 2017
Rox1 (3,700
nucleotides) Rox2
(1,200 nucleotides)
cis and
trans
Male specific nuclear RNAs.
Dosage compensation.
Rox1: three stable helices
connected by flexible linker
regions. Rox2: two clusters of
tandem stem-loops.
In vitro using chemical
probing with SHAPE and
PARS analysis. Both methods
independently support the
rox2 structure model.
Siegfried et al., 2014
SRA (870
nucleotides)
trans Interacts with SRA protein to
regulate cardiac muscle
differentiation.
Four distinct domains. In vitro SHAPE and DMS
chemical probing. Good
agreement with RNase VI
enzymatic probing.
Watters et al., 2016;
Mustoe et al., 2018
HOTAIR (2,148
nucleotides)
trans Associated with sporadic
thoracic aortic aneurysm
and non-end stage heart
failure. Circulating biomarker
for acute myocardial
infarction and congenital
heart diseases.
Four structural modules. In vitro using chemical
probing with SHAPE and
DMS reagents.
Arieti et al., 2014; Lu et al.,
2016; Smola et al., 2016;
Watters et al., 2016; Busan
and Weeks, 2017
Braveheart (590
nucleotides)
trans Cardiovascular lineage
commitment.
Three domains. Critical
structure: a 5′ asymmetric
G-rich internal loop (AGIL).
In vitro using chemical
probing with SHAPE and
DMS reagents.
Liu et al., 2017a
aortic smooth muscle cells apoptosis, this lncRNA plays a
key role in the cardiovascular system (Guo et al., 2017). In
non-end stage heart failure patients HOTAIR was among a
panel of lncRNAs that were significantly modulated (Greco
et al., 2016). A protective role of HOTAIR in cardiomyocytes
(Gao et al., 2017) and as a circulating biomarker for acute
myocardial infarction and congenital heart diseases were also
proposed (Jiang et al., 2018). Hotair is 2,148 nucleotides long
making the structural determination extremely challenging. To
address this issue a non-denaturing purification protocol
to obtain a homogeneous and monodisperse form was
established. Structural modules and distinct evolutionary
conserved elements were determined in vitro using chemical
probing with SHAPE and DMS reagents (Somarowthu et al.,
2015).
Braveheart
Braveheart is a 590 nucleotide lncRNA that acts in trans
to regulate cardiovascular lineage commitment. Its secondary
structure was experimentally assessed using SHAPE and DMS
probing in vitro. It emerged that Braveheart is organized into a
highly intricate modular structure comprising of three domains,
consisting of 12 helices, 8 terminal loops, 5 sizeable internal loops,
and a five-way junction. Intriguingly, it includes a 5′ asymmetric
G-rich internal loop (AGIL) and a 55 nucleotide stretch at
the 3′ end exhibiting high reactivity suggesting low probability
of structure. Genetic deletion of this specific 11 nucleotide
fragment demonstrated that the AGIL motif is essential for
mouse embryonic stem cell differentiation to cardiomyocytes
through binding of the zing-finger protein CNBP/ZNF9 (Xue
et al., 2016).
FUTURE DIRECTIONS
RNA structure determination combined with genetic
manipulations can elucidate the important functional
domains of lncRNAs. To this end, advanced experimental
tools, bioinformatics and genome engineering should be
integrated. The CRISPR/Cas9 gene editing system emerged
as a robust technology that can be used to generate targeted
modifications at precise genomic loci. Cas9, a nuclease that
can induce double-stranded breaks (DSBs) to the DNA, can be
guided in the immediate vicinity of the proto-adjacent motif
NGG by an RNA molecule (sgRNA) consisting of a small 20
nucleotide long variable sequence and an adaptor transactivating
RNA. Precise insertions, deletions, or base substitutions can be
introduced at a DSB site (Lin et al., 2014) in primary cells and
in vivo in mouse models of disease (Platt et al., 2014; Abrahimi
et al., 2015). A modified version of the CRISPR/Cas9 system
has recently been employed for genome scale screenings of
functional lncRNAs. This CRISPR interference approach uses a
nuclease dead Cas9 (dCas9) that is not capable of inducing DSB
to the DNA. Fused to a repressor domain (e.g., KRAB) (Liu et al.,
2017b) or an activation domain (e.g., VP64) (Konermann et al.,
2015; Bester et al., 2018) dCas9 and can be guided by sgRNAs
to specific loci in the upstream regulatory region to trigger
repression or activation of lncRNA transcription, respectively.
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Such approaches are extremely useful to test the functionality of
lncRNAs in a high throughput manner.
Once specific lncRNAs are identified, technologies that
can define the lncRNA structure in vivo are critical to
determine lncRNA modules and structural domains. RNA
structure determination can be coupled with comparative
genomics analysis that will take into consideration the positional
conservation and the fact that lncRNAs may rely on short
elements rather than long stretches of conserved sequences.
Genetic studies that can target precisely these structural domains
while maintaining the expression of the lncRNA (Matsumoto
et al., 2017) will delineate the functional impact of these motifs.
The use of CRISPR/Cas9 gene editing in induced pluripotent
stem cells that can be clonally expanded, engineered to harbor
defined deletions of the structural motifs and differentiated to
other cell types (Cochrane et al., 2017; Granata et al., 2017) can
provide conclusive evidence for the functional impact of these
domains in the cardiovascular system. The potential of these
elements as novel targets could be explored further for precise
interventions suitable for therapeutic applications.
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